M E Beutel1, M Blettner, S Fischbeck, C Loquay, A Werner, H Marian. 1. Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie, Universitätsmedizin Mainz, Untere Zahlbacher Str. 8, 55131, Mainz. Beutel@Psychosomatik.Klinik.Uni-Mainz.de
Abstract
BACKGROUND AND METHODS: Despite the increasing prevalence of malignant melanoma, psychosocial aspects have found little attention. A systematic review was conducted in order to identify psycho-oncological articles on patients with malignant melanoma. RESULTS: Out of a total of 31 studies, 12 examine quality of life in malignant melanoma patients and 6 studies monitor quality of life in the course of therapy. Most studies originate from English-speaking countries (USA, UK, AU); few German studies have been published. Methodological limitations of the studies include cross-sectional assessment, unreported return rate, small sample sizes and comparability (heterogeneous or non-standardized psychosocial measures). CONCLUSIONS: In addition to the tumor stage, psychosocial characteristics (coping with disease, social support) have a substantial effect on quality of life. Results from psychotherapy trials with malignant melanoma patients are encouraging. Given the overall high survival rates of malignant melanoma, quality of life and needs for care of long-term survivors need to be assessed.
BACKGROUND AND METHODS: Despite the increasing prevalence of malignant melanoma, psychosocial aspects have found little attention. A systematic review was conducted in order to identify psycho-oncological articles on patients with malignant melanoma. RESULTS: Out of a total of 31 studies, 12 examine quality of life in malignant melanomapatients and 6 studies monitor quality of life in the course of therapy. Most studies originate from English-speaking countries (USA, UK, AU); few German studies have been published. Methodological limitations of the studies include cross-sectional assessment, unreported return rate, small sample sizes and comparability (heterogeneous or non-standardized psychosocial measures). CONCLUSIONS: In addition to the tumor stage, psychosocial characteristics (coping with disease, social support) have a substantial effect on quality of life. Results from psychotherapy trials with malignant melanomapatients are encouraging. Given the overall high survival rates of malignant melanoma, quality of life and needs for care of long-term survivors need to be assessed.
Authors: L Baider; S M Russak; S Perry; K Kash; M Gronert; B Fox; J Holland; A Kaplan-Denour Journal: Psychooncology Date: 1999 Jan-Feb Impact factor: 3.894
Authors: Dorothée Nashan; Franz Kirschner; Gerhard Strittmatter; Frank Hirche; Peter Hensen; Carmen Loquai; Cornelia Mauch Journal: J Dtsch Dermatol Ges Date: 2004-02 Impact factor: 5.584
Authors: M F Avril; S Aamdal; J J Grob; A Hauschild; P Mohr; J J Bonerandi; M Weichenthal; K Neuber; T Bieber; K Gilde; V Guillem Porta; J Fra; J Bonneterre; P Saïag; D Kamanabrou; H Pehamberger; J Sufliarsky; J L Gonzalez Larriba; A Scherrer; Y Menu Journal: J Clin Oncol Date: 2004-03-15 Impact factor: 44.544
Authors: Susan A Oliveria; Jennifer L Hay; Alan C Geller; Maureen K Heneghan; Mary S McCabe; Allan C Halpern Journal: J Cancer Surviv Date: 2007-03 Impact factor: 4.442
Authors: Sabine Fischbeck; Barbara H Imruck; Maria Blettner; Veronika Weyer; Harald Binder; Sylke R Zeissig; Katharina Emrich; Peter Friedrich-Mai; Manfred E Beutel Journal: PLoS One Date: 2015-08-21 Impact factor: 3.240
Authors: Sabine Fischbeck; Veronika Weyer-Elberich; Sylke R Zeissig; Barbara H Imruck; Maria Blettner; Harald Binder; Manfred E Beutel Journal: BMC Public Health Date: 2018-04-17 Impact factor: 3.295
Authors: Carmen Loquai; Vera Scheurich; Nils Syring; Irene Schmidtmann; Stephan Rietz; Andreas Werner; Stephan Grabbe; Manfred E Beutel Journal: PLoS One Date: 2013-07-05 Impact factor: 3.240
Authors: Ryan G Gamble; Daniel Jensen; Andrea L Suarez; Anne H Hanson; Lauren McLaughlin; Jodi Duke; Robert P Dellavalle Journal: Cancers (Basel) Date: 2010-06-07 Impact factor: 6.639